Impact Report

A new collaboration between the lab of Prof. Gökhan Hotamışlıgil at Harvard T.H. Chan School of Public Health and İş Private Equity of Istanbul aims to translate groundbreaking discoveries about a protein that helps regulate metabolism and inflammation.

LAB eN2, an accelerator established through a strategic corporate alliance with Evotec and Novo Nordic, provides support to a research project in the lab of Prof. Sloan Devlin at Harvard Medical School.

A research team in the Department of Stem Cell and Regenerative Biology, led by Prof. Lee Rubin and Harvard research scientist Feodor Price, developed a new tool for generating large numbers of muscle stem cells, in vitro. This research was supported by the Blavatnik Biomedical Accelerator and a strategic alliance with National Resilience.

Prof. Evelyn Hu and a research team at the John A. Paulson School of Engineering and Applied Sciences have developed a platform for manipulating qubits in silicon for quantum networks. This research was supported by a research alliance with AWS.

A research team led by Jennifer Lewis, a Wyss Core Faculty member and professor at the John A. Paulson School of Engineering and Applied Sciences, has developed a new printing method that creates branching vessels in heart tissue, mimicking the structure of human vasculature in vitro.

The Harvard Move Lab at the John A. Paulson School of Engineering and Applied Sciences is led by Faculty Director Prof. Conor Walsh and Executive Director Prof. Paul Sabin. With past support from the Wyss Institute, the research team is developing a robotic device for stroke survivors.

A Blavatnik Biomedical Accelerator-supported research project led by Bernardo Sabatini, professor at Harvard Medical School and director of the Kempner Institute at Harvard University, and Daniel Hochbaum, research fellow in the Blavatnik Institute at HMS, shows that thyroid hormone changes the wiring of brain circuits in a manner that drives animals to engage in exploratory behavior.

A Blavatnik Biomedical Accelerator-supported research project led by Prof. Paola Arlotta at Harvard’s Department of Stem Cell and Regenerative Biology has resulted in a platform that could help scientists better understand the human brain and its responses to various stimuli.

Prof. Sloan Devlin and other chemists in her field discuss advancements made to uncover the mechanisms through which the microbiome impacts our health. The Blavatnik Biomedical Accelerator supported related research from Prof. Devlin’s lab.

GC Therapeutics announced the launch of its technology, TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies across multiple therapeutic areas. The research team out of Prof. George Church’s lab at Harvard Medical School received instrumental funding and consultation support from Harvard’s Blavatnik Biomedical Accelerator, along with support from the Wyss Institute.

Kinvard Bio launched with new compounds developed in Prof. Andrew Myers lab at Harvard’s Department of Chemistry and Chemical Biology in the hopes of treating drug-resistant infections and diseases. Kelvin Wu and Ben Tresco, co-founders of Kinvard Bio, co-led the research team. The research project advanced to startup formation with support from the Blavatnik Biomedical Accelerator and Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).

Rarefied Technologies, a startup from Prof. Joost Vlassak’s lab at the Harvard John A. Paulson School of Engineering and Applied Sciences, has developed technology that can access the mesosphere, the unexplored region between the upper and lower atmospheres. The Harvard Grid Accelerator supported this research project.

Prof. Jonathan Grinham from Harvard’s Graduate School of Design collaborated with staff scientist Jack Alvarenga and others in Prof. Joanna Aizenberg’s lab at the John A. Paulson School of Engineering and Applied Sciences to develop a technology to enable a more efficient air conditioning and dehumidification system. Initial research was supported by the Wyss Institute and Harvard’s Office of the Vice Provost for Climate and Sustainability. The team received support from the Harvard Grid Accelerator for their advanced technology and launched Trellis Air.

Axoft, a startup based on foundational research out of Prof. Jia Liu’s lab at the John A. Paulson School of Engineering and Applied Sciences and Prof. Hongkun Park’s lab at Harvard’s Department of Chemistry and Chemical Biology, is developing a soft, safer brain implant to measure brain activity in patients with traumatic brain injuries.